Tuesday 22 June 2021, 11:00 – 18:00
EASL Clinical Practice Guidelines on Non-invasive Tests for evaluation of liver disease severity and prognosis- 2021 Update
Programme
Introduction and methodology used, including panel members and Delphi panel members
Annalisa Berzigotti, Switzerland
General population
Emmanuel Tsochatzis, United Kingdom
Alcohol related liver disease
Maja Thiele, Denmark
Non-alcoholic fatty liver disease: diagnosis of steatosis and diagnosis of liver fibrosis
Laurent Castera, France
Non-alcoholic fatty liver disease: prognosis; patient selection and evaluation of treatment response in therapeutic trials
Jerome Boursier, France
Chronic hepatitis C post sustained virological response
Salvatore Petta, Italy
Cholestatic and autoimmune liver disease
Nora Cazzagon, Italy
Compensated advanced chronic liver disease and portal hypertension
Annalisa Berzigotti, Switzerland
Log in to post comments